|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5614184A
(en)
*
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
|
US5989538A
(en)
*
|
1995-02-15 |
1999-11-23 |
Amgen Inc. |
Mpl ligand analogs
|
|
US5696250A
(en)
*
|
1995-02-15 |
1997-12-09 |
Amgen Inc. |
DNA encoding megakaryocyte growth and development factor analogs
|
|
WO1997013783A1
(en)
*
|
1995-10-09 |
1997-04-17 |
Pharmacia & Upjohn Company |
An acceptor polypeptide for an n-acetylgalactosaminyltransferase
|
|
KR100400637B1
(ko)
*
|
1996-02-06 |
2004-03-10 |
씨제이 주식회사 |
생물학적으로유용한펩타이드
|
|
ATE247667T1
(de)
|
1996-03-14 |
2003-09-15 |
Genentech Inc |
Gdnf-rezeptor und dessen verwendung
|
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
|
ES2208798T3
(es)
*
|
1997-09-01 |
2004-06-16 |
Aventis Pharma Deutschland Gmbh |
Eritropoyetina humana recombinante con un perfil de glicosilacion ventajoso.
|
|
EP1489100B1
(en)
|
1997-12-08 |
2016-06-15 |
Merck Patent GmbH |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
|
|
ATE339507T1
(de)
|
1998-06-15 |
2006-10-15 |
Gtc Biotherapeutics Inc |
Erythropoietin-analog-menschliches serum-albumin fusionsprotein
|
|
US7304150B1
(en)
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
PT1813624E
(pt)
†
|
1998-10-23 |
2010-10-27 |
Amgen Inc |
Métodos e composições para a prevenção e tratamento da anemia
|
|
DE19857609A1
(de)
|
1998-12-14 |
2000-06-15 |
Hannelore Ehrenreich |
Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
|
|
ES2257287T3
(es)
*
|
1999-02-12 |
2006-08-01 |
Amgen Inc. |
Composiciones de leptina glicosiladas y metodos relacionados.
|
|
US7410941B1
(en)
|
1999-04-13 |
2008-08-12 |
The Kenneth S. Warren Institute, Inc. |
Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
|
|
US7345019B1
(en)
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
|
US7604960B2
(en)
|
1999-04-15 |
2009-10-20 |
Crucell Holland B.V. |
Transient protein expression methods
|
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
US8236561B2
(en)
|
1999-04-15 |
2012-08-07 |
Crucell Holland B.V. |
Efficient production of IgA in recombinant mammalian cells
|
|
US6855544B1
(en)
|
1999-04-15 |
2005-02-15 |
Crucell Holland B.V. |
Recombinant protein production in a human cell
|
|
US6831060B2
(en)
|
1999-05-07 |
2004-12-14 |
Genentech, Inc. |
Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
|
US6555343B1
(en)
|
1999-05-07 |
2003-04-29 |
Genentech Inc. |
Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
|
MXPA01011264A
(es)
*
|
1999-05-07 |
2002-07-02 |
Genentech Inc |
Nuevos polipeptidos de eritropoyetina de chimpance (chepo) y aciodos nucleicos que codifican los mismos.
|
|
JO2291B1
(en)
*
|
1999-07-02 |
2005-09-12 |
اف . هوفمان لاروش ايه جي |
Erythropoietin derivatives
|
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
RU2232163C2
(ru)
*
|
1999-07-02 |
2004-07-10 |
Ф.Хоффманн-Ля Рош Аг |
Конъюгаты эритропоэтина и полиэтиленгликоля, фармацевтические композиции (варианты), способ профилактического и/или терапевтического лечения нарушений и способ получения коньюгата или композиции
|
|
US7067110B1
(en)
|
1999-07-21 |
2006-06-27 |
Emd Lexigen Research Center Corp. |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
JP4793971B2
(ja)
|
1999-08-09 |
2011-10-12 |
メルク パテント ゲーエムベーハー |
複合サイトカイン−抗体複合体
|
|
EP1228214A2
(en)
*
|
1999-11-12 |
2002-08-07 |
MERCK PATENT GmbH |
Erythropoietin forms with improved properties
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7192759B1
(en)
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7527961B2
(en)
|
1999-11-26 |
2009-05-05 |
Crucell Holland B.V. |
Production of vaccines
|
|
HUP0204475A2
(en)
|
2000-02-11 |
2003-04-28 |
Merck Patent Gmbh |
Enhancing the circulating half-life of antibody-based fusion proteins
|
|
US6586398B1
(en)
*
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
|
EP2206720A1
(en)
|
2000-04-12 |
2010-07-14 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
WO2001081405A2
(en)
*
|
2000-04-21 |
2001-11-01 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
PL219131B1
(pl)
|
2000-05-15 |
2015-03-31 |
Hoffmann La Roche |
Ciekła kompozycja farmaceutyczna, sposób jej wytwarzania oraz jej zastosowanie
|
|
US7259146B2
(en)
|
2000-05-26 |
2007-08-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Neuroprotective peptides
|
|
DE60129695T2
(de)
|
2000-06-29 |
2008-06-05 |
Merck Patent Gmbh |
Steigerung von durch antikörper-zytokin-fusionsproteine mediierten immunantworten durch eine kombinierte behandlung mit mitteln zur erhöhung der immunzytokinaufnahme
|
|
WO2002011753A1
(en)
|
2000-08-04 |
2002-02-14 |
Chugai Seiyaku Kabushiki Kaisha |
Protein injection preparations
|
|
US8632778B2
(en)
|
2000-08-11 |
2014-01-21 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilized anti-interleukin-6 antibody-containing preparations
|
|
KR101229995B1
(ko)
|
2000-12-11 |
2013-02-06 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
DE60117919T2
(de)
*
|
2000-12-11 |
2006-12-14 |
Cheil Jedang Corp. |
Fusionsprotein mit verbesserter in vivo erythropoietinwirkung
|
|
CA2431964C
(en)
|
2000-12-20 |
2013-09-10 |
F. Hoffmann-La Roche Ag |
Conjugates of erythropoietin (pep) with polyethylene glycol (peg)
|
|
US20030072737A1
(en)
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
|
US7767643B2
(en)
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
US6531121B2
(en)
|
2000-12-29 |
2003-03-11 |
The Kenneth S. Warren Institute, Inc. |
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
DK1471871T3
(da)
|
2001-02-02 |
2007-09-17 |
Ortho Mcneil Pharm Inc |
Behandling af neurologisk dysfunktion omfattende fructopyranosesulfamater og erytropoietin
|
|
AU2002248571B2
(en)
|
2001-03-07 |
2007-01-18 |
Merck Patent Gmbh |
Expression technology for proteins containing a hybrid isotype antibody moiety
|
|
EP3088412B1
(en)
|
2001-03-09 |
2021-05-05 |
Chugai Seiyaku Kabushiki Kaisha |
Protein purification method
|
|
DE10112825A1
(de)
|
2001-03-16 |
2002-10-02 |
Fresenius Kabi De Gmbh |
HESylierung von Wirkstoffen in wässriger Lösung
|
|
WO2002079415A2
(en)
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
|
FR2823220B1
(fr)
*
|
2001-04-04 |
2003-12-12 |
Genodyssee |
Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
|
|
EP2975382B1
(en)
|
2001-04-17 |
2017-12-27 |
Chugai Seiyaku Kabushiki Kaisha |
Method of quantifying surfactant
|
|
PT1383785E
(pt)
|
2001-05-03 |
2011-06-28 |
Merck Patent Gmbh |
Anticorpo recombinante específico de tumores e utilização deste
|
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
US7214660B2
(en)
*
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
|
JP2005530678A
(ja)
|
2001-11-28 |
2005-10-13 |
オーソーマクニール ファーマシューティカル， インコーポレイテッド |
貧血治療用のエリスロポエチン投与療法
|
|
KR100467750B1
(ko)
*
|
2001-11-29 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
KR100467751B1
(ko)
*
|
2001-12-03 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
PT1454138E
(pt)
|
2001-12-04 |
2012-03-28 |
Merck Patent Gmbh |
Imunocitoquinas com seletividade modulada
|
|
KR100979025B1
(ko)
|
2001-12-07 |
2010-08-30 |
크루셀 홀란드 비.브이. |
바이러스, 바이러스 단리물 및 백신의 생산
|
|
EP2261250B1
(en)
|
2001-12-21 |
2015-07-01 |
Human Genome Sciences, Inc. |
GCSF-Albumin fusion proteins
|
|
DE10209822A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
|
|
DE10209821A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
|
WO2003078959A2
(en)
|
2002-03-11 |
2003-09-25 |
Ortho Mcneil Pharmaceutical, Inc |
Methods for shp1 mediated neuroprotection
|
|
US20030191056A1
(en)
|
2002-04-04 |
2003-10-09 |
Kenneth Walker |
Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
|
|
CA2491567A1
(en)
*
|
2002-07-01 |
2004-01-08 |
The Kenneth S. Warren Institute, Inc. |
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
|
|
WO2004009627A1
(en)
*
|
2002-07-19 |
2004-01-29 |
Cangene Corporation |
Pegylated erythropoietic compounds
|
|
DE10234192B4
(de)
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
|
EP1541165A4
(en)
|
2002-08-27 |
2009-06-24 |
Chugai Pharmaceutical Co Ltd |
METHOD FOR STABILIZING PROTEIN PREPARATION
|
|
US7459435B2
(en)
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
|
DE60332358D1
(de)
*
|
2002-09-09 |
2010-06-10 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
|
DE20321793U1
(de)
|
2002-09-11 |
2010-06-02 |
Fresenius Kabi Deutschland Gmbh |
Hydroxyalkylstärke-Derivate
|
|
BR0314106A
(pt)
|
2002-09-11 |
2005-07-19 |
Fresenius Kabi De Gmbh |
Polipeptìdeos hasilados, especialmente eritropoietina hasilada
|
|
EP1681303B1
(en)
|
2002-09-11 |
2013-09-04 |
Fresenius Kabi Deutschland GmbH |
HASylated polypeptides, especially HASylated erythropoietin
|
|
ES2558303T3
(es)
|
2002-09-11 |
2016-02-03 |
Chugai Seiyaku Kabushiki Kaisha |
Método de purificación de proteínas
|
|
ATE409048T1
(de)
|
2002-10-08 |
2008-10-15 |
Fresenius Kabi De Gmbh |
Pharmazeutisch aktive oligosaccharid-conjugate
|
|
CA2502539A1
(en)
*
|
2002-10-17 |
2004-04-29 |
Pharming Intellectual Property B.V. |
Protein modification
|
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
|
CN100432105C
(zh)
|
2002-12-17 |
2008-11-12 |
默克专利有限公司 |
与gd2结合的小鼠14.18抗体的人源化抗体(h14.18)以及其与il-2的融合
|
|
CA2513213C
(en)
|
2003-01-22 |
2013-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
EP2055189A1
(en)
|
2003-04-09 |
2009-05-06 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
CN100383238C
(zh)
|
2003-05-09 |
2008-04-23 |
克鲁塞尔荷兰公司 |
E1-永生化的细胞培养物及培养所述细胞以提高从中获取的产物产量的方法
|
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
|
KR100632985B1
(ko)
*
|
2003-07-26 |
2006-10-11 |
메덱스젠 주식회사 |
생리활성 조절 단백질의 효능 향상 방법 및 그 예시변이체들
|
|
WO2005014655A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
|
BRPI0414887A
(pt)
|
2003-09-29 |
2006-12-12 |
Warren Pharmaceuticals Inc E T |
métodos de tratamento, prevenção, retardo do inìcio ou redução dos efeitos de citocinas pró-inflamatórias em um mamìfero e de tratamento, prevenção, retardo do inìcio de uma condição associada com um efeito de citocinas pró-inflamatórias em um mamìfero, e, composição farmacêutica
|
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
|
AU2004309083B2
(en)
|
2003-12-30 |
2010-11-11 |
Augustinus Bader |
Tissue regeneration method
|
|
JP2008504008A
(ja)
|
2003-12-31 |
2008-02-14 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
改良された薬物動態を有するＦｃ−エリスロポエチン融合タンパク質
|
|
DE102004063927A1
(de)
|
2004-01-23 |
2005-12-15 |
Epoplus Gmbh Co.Kg |
Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
|
|
TWI417303B
(zh)
|
2004-03-11 |
2013-12-01 |
Fresenius Kabi De Gmbh |
經由還原胺化作用製得之羥烷基澱粉及蛋白質的接合物
|
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
US20080176790A1
(en)
|
2004-10-29 |
2008-07-24 |
Defrees Shawn |
Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
|
|
US9029331B2
(en)
|
2005-01-10 |
2015-05-12 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
|
US20070154992A1
(en)
|
2005-04-08 |
2007-07-05 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
|
EP1736481A1
(en)
|
2005-05-13 |
2006-12-27 |
Charite Universitätsmedizin-Berlin |
Erythropoietin variants
|
|
US9988427B2
(en)
|
2005-05-13 |
2018-06-05 |
Charite Universitaetsmedizen-Berlin |
Erythropoietin variants
|
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
CN100432107C
(zh)
*
|
2005-10-25 |
2008-11-12 |
北京大学 |
具有促红细胞生长因子活性的蛋白质及其用途
|
|
WO2007056191A2
(en)
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
|
AU2006322028C1
(en)
|
2005-12-08 |
2025-09-04 |
Amgen Inc. |
Improved host cells and culture methods
|
|
EP3026109B1
(en)
|
2005-12-08 |
2022-03-09 |
Amgen Inc. |
Improved production of glycoproteins using manganese
|
|
DE102006004008A1
(de)
|
2006-01-27 |
2007-08-02 |
Hannelore Prof. Dr. Dr. Ehrenreich |
Verfahren zur Behandlung und/oder Prophylaxe von Multipler Sklerose, sowie Verwendung von Erythropoietin zur Herstellung eines Arzneimittels zur intermittierenden Behandlung und/oder intermittierenden Prophylaxe von Multipler Sklerose
|
|
JP5553506B2
(ja)
|
2006-03-22 |
2014-07-16 |
中外製薬株式会社 |
エリスロポエチン溶液製剤
|
|
CN101062407A
(zh)
|
2006-04-29 |
2007-10-31 |
中国科学院上海生命科学研究院 |
促红细胞生成素在预防或治疗视网膜损伤中的用途
|
|
MX2008014744A
(es)
|
2006-05-19 |
2009-02-10 |
Glycofi Inc |
Composiciones de eritrocpoyetina.
|
|
ES2516694T3
(es)
|
2006-07-21 |
2014-10-31 |
Ratiopharm Gmbh |
Glicosilación de péptidos a través de secuencias de glicosilación con unión en O
|
|
MX2009000685A
(es)
|
2006-07-21 |
2009-01-30 |
Amgen Inc |
Metodo para detectar y/o cuantificar hepcidina en una muestra.
|
|
CN101505788B
(zh)
|
2006-08-22 |
2013-06-26 |
中外制药株式会社 |
周围神经病变的预防和/或治疗药
|
|
US8969532B2
(en)
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
|
CN101337988B
(zh)
*
|
2006-10-31 |
2013-01-09 |
沈阳三生制药有限责任公司 |
一种新的促红细胞生成素类似物
|
|
EP2081956B1
(en)
|
2006-11-13 |
2013-03-20 |
Charité - Universitätsmedizin Berlin |
Method of cell culture and method of treatment comprising a vepo protein variant
|
|
CN101678079B
(zh)
|
2006-11-28 |
2013-12-25 |
韩诺生物制约株式会社 |
修饰的促红细胞生成素多肽及其治疗用途
|
|
AR065613A1
(es)
|
2007-03-09 |
2009-06-17 |
Chugai Pharmaceutical Co Ltd |
Agentes de proteccion para organos transplantados
|
|
KR20100016160A
(ko)
|
2007-04-03 |
2010-02-12 |
바이오제너릭스 에이지 |
글리코페길화 ｇ―ｃｓｆ를 이용하는 치료 방법
|
|
WO2008154639A2
(en)
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Improved process for the production of nucleotide sugars
|
|
WO2008151841A2
(en)
*
|
2007-06-15 |
2008-12-18 |
University Of Zurich |
Treatment for alzheimer' s disease
|
|
RU2335296C1
(ru)
*
|
2007-06-26 |
2008-10-10 |
Сергей Марович Дудкин |
Фармацевтическая композиция для профилактики и лечения неврологических заболеваний
|
|
CN103073631A
(zh)
*
|
2007-07-02 |
2013-05-01 |
沈阳三生制药有限责任公司 |
一种促红细胞生成素类似物
|
|
CN103113464B
(zh)
*
|
2007-07-02 |
2014-08-20 |
沈阳三生制药有限责任公司 |
天然人促红细胞生成素类似物
|
|
WO2009010107A1
(en)
|
2007-07-19 |
2009-01-22 |
Hannelore Ehrenreich |
Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis
|
|
EP2205280B1
(en)
|
2007-09-27 |
2019-09-04 |
Amgen Inc. |
Pharmaceutical formulations
|
|
EP2219602A1
(en)
|
2007-11-15 |
2010-08-25 |
Amgen, Inc |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
|
EP2070950A1
(en)
|
2007-12-14 |
2009-06-17 |
Fresenius Kabi Deutschland GmbH |
Hydroxyalkyl starch derivatives and process for their preparation
|
|
ES2500066T3
(es)
|
2008-01-25 |
2014-09-30 |
Amgen, Inc |
Anticuerpos frente a ferroportina y métodos de uso
|
|
NZ586947A
(en)
|
2008-02-08 |
2012-11-30 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
|
KR101582841B1
(ko)
|
2008-02-27 |
2016-01-11 |
노보 노르디스크 에이/에스 |
콘쥬게이트된 인자 ｖｉｉｉ 분자
|
|
EP2095829A1
(en)
|
2008-02-27 |
2009-09-02 |
LEK Pharmaceuticals D.D. |
Selenium containing modifying agents and conjugates
|
|
CN102105582A
(zh)
|
2008-04-21 |
2011-06-22 |
诺沃-诺迪斯克有限公司 |
高糖基化人凝血因子ix
|
|
CA2722600C
(en)
|
2008-05-01 |
2014-01-21 |
Amgen Inc. |
Anti-hepcidin antibodies and methods of use
|
|
CA2736141C
(en)
|
2008-09-23 |
2018-03-20 |
F. Hoffmann-La Roche Ag |
Purification of erythropoietin
|
|
MX2011003272A
(es)
|
2008-09-26 |
2011-04-28 |
Ambrx Inc |
Polipeptidos de eritropoyetina animal modificados y sus usos.
|
|
JP6018753B2
(ja)
|
2008-11-13 |
2016-11-02 |
ザ・ジェネラル・ホスピタル・コーポレイションＴｈｅ Ｇｅｎｅｒａｌ Ｈｏｓｐｉｔａｌ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｂｍｐ−６の調節によって鉄の恒常性を制御するための方法および組成物
|
|
SI2398817T2
(sl)
*
|
2009-02-19 |
2021-09-30 |
Xellia Pharmaceuticals Aps |
Postopek čiščenja lipopeptidov
|
|
US20100272816A1
(en)
|
2009-04-27 |
2010-10-28 |
Wolfgang Rudinger |
Microcapsules comprising liver cells and erythropoietin, methods for preparing said microcapsules and methods for treating a patient comprising applying said microcapsules to the patient
|
|
WO2011011674A2
(en)
|
2009-07-24 |
2011-01-27 |
Dr. Reddy's Laboratories Ltd. |
Production of erythropoiesis stimulating protein using metal ions
|
|
WO2011024025A1
(en)
*
|
2009-08-28 |
2011-03-03 |
Avesthagen Limited |
An erythropoietin analogue and a method thereof
|
|
MX344382B
(es)
|
2009-10-23 |
2016-12-14 |
Amgen Inc * |
Adaptador de vial y sistema.
|
|
WO2011156373A1
(en)
|
2010-06-07 |
2011-12-15 |
Amgen Inc. |
Drug delivery device
|
|
US20120115637A1
(en)
|
2010-06-30 |
2012-05-10 |
Nike, Inc. |
Golf Balls Including A Crosslinked Thermoplastic Polyurethane Cover Layer Having Improved Scuff Resistance
|
|
US8193296B2
(en)
|
2010-06-30 |
2012-06-05 |
Nike, Inc. |
Golf balls including crosslinked thermoplastic polyurethane
|
|
RU2451071C1
(ru)
*
|
2010-12-10 |
2012-05-20 |
Российская Федерация, от имени которой выступает Министерство образования и науки Российской Федерации (Минобрнауки России) |
Штамм гибридных культивируемых клеток животных mus musculus - продуцент моноклональных антител к рекомбинантному эритропоэтину человека (варианты)
|
|
CA2831100C
(en)
|
2011-03-31 |
2020-02-18 |
Mark Dominis Holt |
Vial adapter and system
|
|
EP2699293B8
(en)
|
2011-04-20 |
2022-07-20 |
Amgen Inc. |
Autoinjector apparatus
|
|
US9089739B2
(en)
|
2011-08-23 |
2015-07-28 |
Nike, Inc. |
Multi-core golf ball having increased initial velocity
|
|
US8979676B2
(en)
|
2011-08-23 |
2015-03-17 |
Nike, Inc. |
Multi-core golf ball having increased initial velocity at high swing speeds relative to low swing speeds
|
|
ES2675035T3
(es)
|
2011-10-14 |
2018-07-05 |
Amgen, Inc |
Inyector y método de ensamblaje
|
|
KR101443257B1
(ko)
*
|
2011-10-18 |
2014-09-19 |
주식회사 종근당 |
낮은 등전점을 갖는 에리스로포이에틴 유사체의 정제방법
|
|
CN102788720B
(zh)
*
|
2012-06-05 |
2016-01-06 |
西北大学 |
一种滤膜辅助分离生物样本中糖蛋白全n-连接糖链及其鉴别方法
|
|
EP3656426B1
(en)
|
2012-11-21 |
2023-05-17 |
Amgen Inc. |
Drug delivery device
|
|
CN103864913A
(zh)
*
|
2012-12-18 |
2014-06-18 |
联亚生技开发股份有限公司 |
重组蛋白
|
|
US9657098B2
(en)
|
2013-03-15 |
2017-05-23 |
Intrinsic Lifesciences, Llc |
Anti-hepcidin antibodies and uses thereof
|
|
EP2968760B1
(en)
|
2013-03-15 |
2024-01-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
SG11201507417RA
(en)
|
2013-03-15 |
2015-10-29 |
Amgen Inc |
Body contour adaptable autoinjector device
|
|
CA2904661C
(en)
|
2013-03-15 |
2022-03-15 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
IL292270B2
(en)
|
2013-03-22 |
2024-04-01 |
Amgen Inc |
Injector and method of assembly
|
|
MX373358B
(es)
|
2013-10-24 |
2020-07-06 |
Amgen Inc |
Inyector y método de montaje.
|
|
ES3062706T3
(en)
|
2013-10-24 |
2026-04-13 |
Amgen Inc |
Drug delivery system with temperature-sensitive control
|
|
KR101414897B1
(ko)
|
2013-11-29 |
2014-07-04 |
씨제이헬스케어 주식회사 |
다베포에틴 알파의 정제 방법
|
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
KR102496507B1
(ko)
|
2014-05-07 |
2023-02-03 |
암겐 인코포레이티드 |
충격 감소 요소들을 가진 자동 주사기
|
|
US20170103186A1
(en)
|
2014-06-03 |
2017-04-13 |
Amgen Inc. |
Systems and methods for supporting patient use of a drug delivery device
|
|
EP3194429A4
(en)
*
|
2014-09-18 |
2018-06-13 |
Askgene Pharma, Inc. |
Novel feline erythropoietin receptor agonists
|
|
AU2015321462B2
(en)
|
2014-09-22 |
2020-04-30 |
Intrinsic Lifesciences Llc |
Humanized anti-hepcidin antibodies and uses thereof
|
|
EP3206739B1
(en)
|
2014-10-14 |
2021-12-01 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
US11357916B2
(en)
|
2014-12-19 |
2022-06-14 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
WO2016100781A1
(en)
|
2014-12-19 |
2016-06-23 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
CA2976935C
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
EP3261690B1
(en)
|
2015-02-27 |
2021-12-15 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
US11351308B2
(en)
|
2015-12-09 |
2022-06-07 |
Amgen Inc. |
Auto-injector with signaling cap
|
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
JP6906497B2
(ja)
*
|
2016-03-09 |
2021-07-21 |
Ｊｃｒファーマ株式会社 |
変異型ヒトエリスロポエチンの製造方法
|
|
ES2814287T3
(es)
|
2016-03-15 |
2021-03-26 |
Amgen Inc |
Reducir la probabilidad de rotura de cristal en dispositivos de administración de fármaco
|
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
WO2017192287A1
(en)
|
2016-05-02 |
2017-11-09 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
AU2017263558B2
(en)
|
2016-05-13 |
2022-12-22 |
Amgen Inc. |
Vial sleeve assembly
|
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
GB2550418A
(en)
|
2016-05-20 |
2017-11-22 |
Laing Peter |
An improved vaccine against flaviviruses avoiding elicitation or stimulation of infection-enhancing antibodies
|
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
WO2018004842A1
(en)
|
2016-07-01 |
2018-01-04 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
|
US20190358411A1
(en)
|
2017-01-17 |
2019-11-28 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
US11752258B2
(en)
|
2017-02-17 |
2023-09-12 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
JP6258536B1
(ja)
|
2017-03-03 |
2018-01-10 |
協和発酵キリン株式会社 |
ダルベポエチン組成物の製造方法およびダルべポエチン産生細胞の培養方法
|
|
CA3050927A1
(en)
|
2017-03-06 |
2018-09-13 |
Brian Stonecipher |
Drug delivery device with activation prevention feature
|
|
WO2018164829A1
(en)
|
2017-03-07 |
2018-09-13 |
Amgen Inc. |
Needle insertion by overpressure
|
|
MX2019010671A
(es)
|
2017-03-09 |
2019-10-21 |
Amgen Inc |
Mecanismo de insercion para dispositivo de administracion de farmacos.
|
|
JP2020511499A
(ja)
|
2017-03-20 |
2020-04-16 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
赤血球生成刺激タンパク質のインビトロでの糖鎖改変のための方法
|
|
SG11201907676PA
(en)
|
2017-03-28 |
2019-09-27 |
Amgen Inc |
Plunger rod and syringe assembly system and method
|
|
JP2020522263A
(ja)
|
2017-06-06 |
2020-07-30 |
キンドレッド バイオサイエンシズ インコーポレイテッド |
獣医学的使用のためのエリスロポエチンおよびアナログ
|
|
MX2019014615A
(es)
|
2017-06-08 |
2020-02-07 |
Amgen Inc |
Dispositivo de administracion de farmacos accionado por par de torsion.
|
|
EP3634539A1
(en)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
MX2019015472A
(es)
|
2017-06-22 |
2020-02-19 |
Amgen Inc |
Reduccion del impacto/choque de la activacion del mecanismo.
|
|
AU2018290302B2
(en)
|
2017-06-23 |
2024-02-29 |
Amgen Inc. |
Electronic drug delivery device comprising a cap activated by a switch assembly
|
|
EP3651832B1
(en)
|
2017-07-14 |
2023-12-13 |
Amgen Inc. |
Needle insertion-retraction system having dual torsion spring system
|
|
US11672733B2
(en)
|
2017-07-21 |
2023-06-13 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
|
WO2019022950A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF
|
|
US11617837B2
(en)
|
2017-07-25 |
2023-04-04 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
|
US11077246B2
(en)
|
2017-08-18 |
2021-08-03 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
EP3691717B1
(en)
|
2017-10-04 |
2023-02-08 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
CN111132711B
(zh)
|
2017-10-06 |
2022-07-01 |
安进公司 |
带有联锁组件的药物递送装置及相关组装方法
|
|
IL273323B2
(en)
|
2017-10-09 |
2024-10-01 |
Amgen Inc |
Drug delivery device with drive assembly and related assembly method
|
|
MA50527A
(fr)
|
2017-11-03 |
2020-09-09 |
Amgen Inc |
Système et approches pour stériliser un dispositif d'administration de médicament
|
|
JP2021501616A
(ja)
|
2017-11-06 |
2021-01-21 |
アムジエン・インコーポレーテツド |
配置及び流量検出を備える薬物送達デバイス
|
|
IL273664B1
(en)
|
2017-11-06 |
2026-02-01 |
Amgen Inc |
Full-fledged assemblies and related methods
|
|
CA3079665A1
(en)
|
2017-11-10 |
2019-05-16 |
Amgen Inc. |
Plungers for drug delivery devices
|
|
MX2020004996A
(es)
|
2017-11-16 |
2020-08-27 |
Amgen Inc |
Un mecanismo de pestillo de puerta para un dispositivo de administracion de farmacos.
|
|
EP3710089A1
(en)
|
2017-11-16 |
2020-09-23 |
Amgen Inc. |
Autoinjector with stall and end point detection
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
MA53379A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
EP3826699A1
(en)
|
2018-07-24 |
2021-06-02 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
CA3103105A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
MA53724A
(fr)
|
2018-09-24 |
2021-12-29 |
Amgen Inc |
Systèmes et procédés de dosage interventionnel
|
|
AR113091A1
(es)
*
|
2018-09-27 |
2020-01-22 |
Univ Nacional Del Litoral |
Eritropoyetina humana modificada
|
|
MA53718A
(fr)
|
2018-09-28 |
2022-01-05 |
Amgen Inc |
Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament
|
|
TWI857975B
(zh)
|
2018-10-02 |
2024-10-11 |
美商安進公司 |
具有內部力傳遞的用於藥物遞送之注射系統
|
|
TW202529830A
(zh)
|
2018-10-05 |
2025-08-01 |
美商安進公司 |
具有劑量指示器之藥物遞送裝置
|
|
MA53912A
(fr)
|
2018-10-15 |
2022-01-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un mécanisme d'amortissement
|
|
EA202191038A1
(ru)
|
2018-10-15 |
2021-07-06 |
Эмджен Инк. |
Способ платформенной сборки для устройства доставки лекарственного средства
|
|
AU2019370159B2
(en)
|
2018-11-01 |
2025-05-29 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
EP3873566B1
(en)
|
2018-11-01 |
2024-11-27 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
WO2020219482A1
(en)
|
2019-04-24 |
2020-10-29 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
JP7608439B2
(ja)
|
2019-08-23 |
2025-01-06 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
|
WO2022159414A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Rochester |
Erythropoietin for gastroinfestinal dysfunction
|
|
KR20240011135A
(ko)
|
2021-05-21 |
2024-01-25 |
암젠 인크 |
약물 용기를 위한 충전 레시피를 최적화하는 방법
|
|
WO2023209074A1
(en)
|
2022-04-28 |
2023-11-02 |
Institut National de la Santé et de la Recherche Médicale |
Methods of restoring erythropoiesis in patients suffering from a sf3b1 mutant myelodysplastic syndrome by correcting coasy mis-splicing
|
|
WO2024094457A1
(en)
|
2022-11-02 |
2024-05-10 |
F. Hoffmann-La Roche Ag |
Method for producing glycoprotein compositions
|
|
WO2026030152A1
(en)
|
2024-07-29 |
2026-02-05 |
Amgen Inc. |
System and method for assessing transferability of a fill recipe
|